Measuring non-dystrophin proteins and diagnosing muscular dystrophy
CA 2083598 A1 · Owner: Ervasti, James M. · Inventors: Campbell, Kevin P.; Ervasti, James M.; Ohlendieck, Kay
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention pertains to the dystrophin-glycoprotein complex of mammalian skeletal muscle and a method of isolating said complex. The components of the complex and methods of separating and isolating said components also pertain to the invention. In addition the invention further relates to a method of detecting and quantifying the loss of a non-dystrophin component of the dystrophin-glycoprotein complex with said loss being indicative of muscular dystrophy.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 23, 1991. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 23, 2011.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 23, 2013.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.